Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. [electronic resource]
Producer: 20120807Description: 85-6 p. digitalISSN:- 0301-0430
- Aged
- Biomarkers -- blood
- Calcimimetic Agents -- therapeutic use
- Chromatography, High Pressure Liquid
- Cinacalcet
- Down-Regulation
- Female
- Humans
- Hyperparathyroidism, Secondary -- blood
- Kidney Diseases -- blood
- Lysophospholipids -- blood
- Male
- Middle Aged
- Naphthalenes -- therapeutic use
- Renal Dialysis -- adverse effects
- Sphingosine -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.